Archive for the ‘Women's Health’ Category

Ladies, a surge of hair loss two times a year is normal

Saturday, January 16th, 2010

DermatologyAre you sometimes worried about the amount of hair that you find in the shower drain? Of course excessive hair loss can be a result of a number of conditions including autoimmune disorders, hypothyroid, low iron, etc. We can be diagnose these with the right tests, but bear in mind that there are two seasonal spikes of hair loss that are normal. This recent paper in the journal Dermatology reports a study of 823 women in which “Analysis of trichograms demonstrated annual periodicity in the growth and shedding of hair, manifested by a maximal proportion of telogen hairs in summer. A second peak seems to exist, though it is less pronounced, in spring. The telogen rates were lowest in late winter.” [Trichograms are examinations of plucked hairs under the microscope. The telogen phase is the resting phase of the hair follicle during which hair is shed.] The authors conclude: “These results confirm the findings of former authors who have indicated seasonal changes in human hair growth, though this is the first study performed systematically in a representative number of women.”

Prenatal phthalates reduce masculinity in boys—screening test available

Saturday, January 2nd, 2010

Internation Journal of AndrologyHormone-mimicking endocrine disruptors are a massive and pervasive environmental problem. This recent paper published in the International Journal of Andrology reports that exposure to one class of potent antiandrogens (they oppose the function of male hormones) called phthalates alter the effects of male hormones on brain development to the extent that there is a measurable effect on masculine play in boys. The authors state, “These data…suggest that prenatal exposure to antiandrogenic phthalates may be associated with less male-typical play behaviour in boys. Our findings suggest that these ubiquitous environmental chemicals have the potential to alter androgen-responsive brain development in humans.” What do you do if you are pregnant or planning a pregnancy? We use a screening blood test for phthalates and parabens. If you need it, physiologically sound and personalized detox protocols are available.

Women: protect against blood clots after surgery

Tuesday, December 29th, 2009

The British Medical Journal just published this research that examined how big a problem blood clots after different types of surgery are for women and how long the danger lasts. “Women were 70 times more likely to be admitted with venous thromboembolism in the first six weeks after an inpatient operation and 10 times more likely after a day case operation. The risks were lower but still substantially increased 7-12 weeks after surgery…” The real surprise here is how long the risk lasts. I customize a surgical support protocol for everyone undergoing an operation and the surgeons are typically surprised at how well the patients recover. It includes systemic enzymes to reduce inflammation, scarring and clotting. This valuable study suggests that the enzymes should be continued for longer than I have recommended in the past. BMJ

Thyroid dysfunction in peri- and post-menopause

Sunday, December 20th, 2009

This paper published in the medical journal Menopause International touches on the huge topic of thyroid dysfunction before, during and after menopause. As the author states, “Thyroid dysfunction is common, especially among women over the age of 50. In caring for peri- and post-menopausal women, it is important to recognize the changing clinical manifestations of thyroid disease with age.” Subclinical hypo and hyperthyroidism (thyroid dysfunction in the presence of normal TSH levels), an extremely important topic that you will see more about here, is noted in particular. The author notes, “…caution is required in diagnosing and treating thyroid dysfunction in women who are taking oral estrogens or selective estrogen receptor modulators.” The functional approach that fully examines and treats the two dozen underlying patterns of thyroid dysfunction with appropriate tests and therapies is far more extensive than indicated here. See Dr. Kharrazian’s book for an overview for the layperson. Recommended book on thyroid conditions

Antidepressants associated with strokes in women

Tuesday, December 15th, 2009

Here we have another good reason to use the body-friendly method of providing native precursors and cofactors to naturally increase neurotransmitters instead of using re-uptake inhibitors. This study just published in the Archives of Internal Medicine found that “Selective serotonin reuptake inhibitor (SSRI) use was associated with increased stroke risk and all-cause mortality…SSRI use was associated with incident hemorrhagic stroke and fatal stroke.” Important: there IS another way, without side effects or hazards, to improve neurotransmitter levels. Contact us for more information.

Resveratrol also candidate for hormone replacement and breast cancer prevention

Thursday, December 3rd, 2009

This study now being published in The Journal of Nutritional Biochemistry details the exceptional ability of resveratrol to stimulate estrogen receptors in a way that can alleviate the effects of estrogen deficiency while at the same time protecting against breast cancer. We have been using a laboratory-certified form of reseveratol for its previously documented effects on insulin, leptin and glucose regulation (it has also extended the lifespan of lab animals—it’s the component in red wine that has been well-publicized). The authors state: “Thus, resveratrol might be the most promising candidate for HRT and chemoprevention of breast cancer due to its estrogenic activity and high antitumor activity.”

SSRI’s associated with congenital malformations in early pregnancy

Wednesday, December 2nd, 2009

Recent research published in the British Medical Journal reveals that selective serotonin reuptake inhibitors (SSRIs), especially Celexa and Zoloft, are associated with an increased prevalence of septal heart defects when their mothers were prescribed them in early pregnancy. As Lapis Light patients know, physiological neurotransmitter support with precursors and co-factors gives the body what it needs to raise neurotransitter levels naturally.

Undernutrition during pregnancy and obesity, type 2 diabetes in your child

Tuesday, December 1st, 2009

This paper in Current Diabetes Reports discusses how the so-called ‘thrifty gene’ effect (the tendency to conserve calories in the form of fat during times of famine, established through gene selection over thousands of years) occurs not only through this selection process, but can also manifest as a ‘thrifty phenotype’ when eating too little during gestation is followed later by overnutrition. This means that eating too little during your pregnancy can promote obesity and type 2 diabetes in your child if they consume excess calories later. Like with most everything else, moderation is key.

Migraine and strokes in women

Monday, November 30th, 2009

Ladies, if you suffer from migraine here is more inspiration for finding a sound solution. As this recent paper published in The Journal of the American Medical Association reports, migraine attacks can be associated with pathological changes in the brain. The association held true only for migraines with aura, and only for women. The authors conclude: “Migraine with aura in midlife was associated with late-life prevalence of cerebellar infarct-like lesions on MRI [infarct = death of tissue due to interruption of blood flow]. This association was statistically significant only for women. This is consistent with the hypothesis that migraine with aura in midlife is associated with late-life vascular disease in the cerebellum and in women.”

Migraines and estrogen

Monday, November 30th, 2009

“Menstrual migraine affects approximately 50% to 60% of female migraineurs,” states the author of a paper published in The Journal of the American Medical Association. Remember that estrogen also functions as a neurotransmitter. As the paper goes on to say, “Biochemical and genetic evidence suggest central and peripheral roles for estrogen in the pathophysiology of menstrual migraine, with potential interactions with excitatory circuits…” I frequently see estrogen dysregulation, often with insufficient clearance at the end of the menstrual cycle, in our functional hormone profiles. Remember it is the free fraction (unbound, biologically active) portion of the hormones that must be measured for a reliable assessment; and the pituitary hormones FSH and LH should always be included for a cycling female. The author concludes: “Epidemiological, pathophysiological, and clinical evidence link estrogen to migraine headaches.”